Clinical Trial Update: Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of Utidelone injection for advanced or metastatic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Solid Tumor | Phase 2 | Status: COMPLETED